PRO‐C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PRO‐C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD

Published:2021-07-08 Issue:11 Volume:5 Page:1860-1872
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Cohen Catherine C.¹²^ORCID,Castillo‐Leon Eduardo¹,Farris Alton B.³,Caltharp Shelley A.³⁴,Cleeton Rebecca L.¹,Sinclair Elizabeth M.¹⁴,Shevell Diane E.⁵,Karsdal Morten A.⁶,Nielsen Mette Juul Fisker⁶,Leeming Diana J.⁶,Vos Miriam B.¹⁴

Affiliation:

1. Department of Pediatrics Emory University School of Medicine Atlanta GA USA

2. Department of Pediatrics University of Colorado Denver Anschutz Medical Campus Aurora CO USA

3. Department of Pathology and Laboratory Medicine Emory University School of Medicine Atlanta GA USA

4. Children’s Healthcare of Atlanta Atlanta GA USA

5. Translational Medicine Bristol Myers Squibb Lawrenceville NJ USA

6. Nordic Bioscience Fibrosis Biology and Biomarkers Herlev Denmark

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1766

Reference39 articles.

1. Prevalence of obesity and severe obesity in US children, 1999-2014

2. The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis

3. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

4. Natural History of NAFLD Diagnosed in Childhood: A Single-Center Study

5. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From NAFLD to HCC: Advances in noninvasive diagnosis;Biomedicine & Pharmacotherapy;2023-09

2. Diagnostic Performance of Biomarker-Based Scores as Predictors of Metabolic Dysfunction-Associated Fatty Liver Disease Risk in Healthy Children;Nutrients;2023-08-21

3. Novel α-Glucosidase Inhibitory Peptides Identified In Silico from Dry-Cured Pork Loins with Probiotics through Peptidomic and Molecular Docking Analysis;Nutrients;2023-08-11

4. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease;World Journal of Hepatology;2023-05-27

5. Chinese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease have lower serum osteocalcin levels compared to individuals with type 2 diabetes mellitus and no liver disease: a single-center cross-sectional study;Journal of Endocrinological Investigation;2022-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3